Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease - PubMed (original) (raw)
Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease
K Hirano et al. Eur Respir J. 2001 Nov.
Free article
Abstract
Proteinase/antiproteinase imbalance is the most widely accepted theory for development of chronic obstructive pulmonary disease (COPD). Mutations of tissue inhibitor of metalloproteinases-2 (TIMP-2) that downregulate its activity may increase the activities of matrix metalloproteinases and result in the degradation of the lung matrix. Polymorphisms of the TIMP-2 gene were investigated in 88 COPD patients and 40 control subjects. The variations were examined by single-strand conformational polymorphism analysis followed by sequencing. Two polymorphisms were identified, +853 GIA and -418 G/C nucleotide substitutions. There was a significant deviation in the genotypic frequencies at +853 and the allele frequencies for G were significantly higher in the COPD patient group than in the control group. For locus -418, the allele frequencies for C in the COPD patient group also tended to be higher than those in the control group. The +853 G/A nucleotide substitution was a silent variant. The -418 G/C substitution was located in the consensus sequence for the Sp1 binding site. These polymorphisms may be associated with the development of chronic obstructive pulmonary disease, decreasing the transcription and stability of the messenger ribonucleic acid, and available as genetic markers of susceptibility to the disease.
Comment in
- Genetics of COPD: present and future.
Hoidal JR. Hoidal JR. Eur Respir J. 2001 Nov;18(5):741-3. doi: 10.1183/09031936.01.00268501. Eur Respir J. 2001. PMID: 11757620 No abstract available.
Similar articles
- Association analysis of tissue inhibitor of metalloproteinase2 gene polymorphisms with COPD in Egyptians.
Hegab AE, Sakamoto T, Uchida Y, Nomura A, Ishii Y, Morishima Y, Mochizuki M, Kimura T, Saitoh W, Kiwamoto T, Iizuka T, Massoud HH, Massoud HM, Hassanein KM, Sekizawa K. Hegab AE, et al. Respir Med. 2005 Jan;99(1):107-10. doi: 10.1016/j.rmed.2004.05.017. Respir Med. 2005. PMID: 15672858 - MMP14 gene polymorphisms in chronic obstructive pulmonary disease.
Saitoh W, Sakamoto T, Hegab AE, Nomura A, Ishii Y, Morishima Y, Kai S, Iizuka T, Kiwamoto T, Matsuno Y, Massoud HH, Massoud HM, Hassanein KM, Sekizawa K. Saitoh W, et al. Int J Mol Med. 2006 Apr;17(4):621-6. Int J Mol Med. 2006. PMID: 16525718 - Matrix metalloproteinase 3 polymorphisms as a potential marker of enhanced susceptibility to lung cancer in chronic obstructive pulmonary disease subjects.
Brzóska K, Bartłomiejczyk T, Sochanowicz B, Cymerman M, Grudny J, Kołakowski J, Kapka-Skrzypczak L, Kruszewski M, Sliwiński P, Roszkowski-Śliż K. Brzóska K, et al. Ann Agric Environ Med. 2014;21(3):546-51. doi: 10.5604/12321966.1120599. Ann Agric Environ Med. 2014. PMID: 25292126 - What do polymorphisms tell us about the mechanisms of COPD?
Li Y, Cho MH, Zhou X. Li Y, et al. Clin Sci (Lond). 2017 Dec 4;131(24):2847-2863. doi: 10.1042/CS20160718. Print 2017 Dec 15. Clin Sci (Lond). 2017. PMID: 29203722 Review. - Metalloproteases/anti-metalloproteases imbalance in chronic obstructive pulmonary disease: genetic factors and treatment implications.
Mocchegiani E, Giacconi R, Costarelli L. Mocchegiani E, et al. Curr Opin Pulm Med. 2011 Dec;17 Suppl 1:S11-9. doi: 10.1097/01.mcp.0000410743.98087.12. Curr Opin Pulm Med. 2011. PMID: 22209925 Review.
Cited by
- Association of genes of protease-antiprotease balance pathway to lung function and emphysema subtypes.
Kukkonen MK, Tiili E, Vehmas T, Oksa P, Piirilä P, Hirvonen A. Kukkonen MK, et al. BMC Pulm Med. 2013 Jun 4;13:36. doi: 10.1186/1471-2466-13-36. BMC Pulm Med. 2013. PMID: 23734748 Free PMC article. - Characterization of a population of small macrophages in induced sputum of patients with chronic obstructive pulmonary disease and healthy volunteers.
Frankenberger M, Menzel M, Betz R, Kassner G, Weber N, Kohlhäufl M, Häussinger K, Ziegler-Heitbrock L. Frankenberger M, et al. Clin Exp Immunol. 2004 Dec;138(3):507-16. doi: 10.1111/j.1365-2249.2004.02637.x. Clin Exp Immunol. 2004. PMID: 15544629 Free PMC article. - Analysis of MMP-7 and TIMP-2 gene polymorphisms in coronary artery disease and myocardial infarction: A Turkish case-control study.
Alp E, Yilmaz A, Tulmac M, Ugras Dikmen A, Cengel A, Yalcin R, Menevse ES. Alp E, et al. Kaohsiung J Med Sci. 2017 Feb;33(2):78-85. doi: 10.1016/j.kjms.2016.12.002. Epub 2017 Jan 12. Kaohsiung J Med Sci. 2017. PMID: 28137415 Free PMC article. - Updates on the COPD gene list.
Bossé Y. Bossé Y. Int J Chron Obstruct Pulmon Dis. 2012;7:607-31. doi: 10.2147/COPD.S35294. Epub 2012 Sep 18. Int J Chron Obstruct Pulmon Dis. 2012. PMID: 23055711 Free PMC article. Review. - No Association of Matrix Metalloproteinase [MMP]-2 (-735C > T) and Tissue Inhibitor of Metalloproteinase [TIMP]-2 (-418G > C) Gene Polymorphisms with Cervical Cancer Susceptibility.
Srivastava P, Pandey S, Mittal B, Mittal RD. Srivastava P, et al. Indian J Clin Biochem. 2013 Jan;28(1):13-8. doi: 10.1007/s12291-012-0237-4. Epub 2012 Jul 3. Indian J Clin Biochem. 2013. PMID: 24381415 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous